Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI75819 | Publish Date: April 2024 | No. of Pages: 180

Global Neurological Disorder Diagnostics Market Companies

  • Natus
  • Addex THERAPEUTICS
  • Advanced Brain Monitoring, Inc
  • Koninklijke Philips N.V
  • Tevogen Bio
  • Hitachi High-Tech Corporation
  • Masimo
  • NIHON KOHDEN CORPORATION
  • F. Hoffmann-La Roche Ltd
  • Medtronic
  • QURALIS CORPORATION
  • Atlantic Health System
  • Fujirebio
  • Siemens Healthineers AG
  • ant-neuro.com

Recent News:

Philips launched their new Azurion neuro biplane system in February 2024, to speed up and improve invasive diagnosis and treatment of neurovascular patients. A new image-guided therapy system for diagnosis, image guidance and therapy assessment solutions for patients with stroke and other neurovascular diseases. The new interventional system aimed to design to achieve better outcomes and enhance 2D & 3D imaging and x-ray detector positioning flexibility. Philips was partnering with customers to improve productivity and access more sustainable and high-quality healthcare.

Neurological Disorder Diagnostics Market By Companies Forecast Period 2025-2035